Browsing by Author Dimitriou, A. A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 14 of 14
TitleAuthor(s)Issue date
Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome: Comparison With Clopidogrel Hydrogen SulfateTsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Ntalas, I. V.; Goudevenos, I. A.; Tselepis, A. D.24-Nov-2015
Association of Serum Paraoxonase-1 With Platelet Responsiveness to Clopidogrel in Patients With Acute Coronary SyndromesTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Ntalas, I. V.; Tellis, C. C.; Goudevenos, I. A.24-Nov-2015
Clopidogrel differentially affects platelet- mediated thrombosis and inflammatory response in patients with acute coronary syndromesKalantzi, K. I.; Dimitriou, A. A.; Milionis, H. J.; Goudevenos, I. A.; Tselepis, A. D.24-Nov-2015
Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfateTsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Ntalas, I. V.; Goudevenos, I. A.; Tselepis, A. D.24-Nov-2015
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Dimitriou, A. A.; Tellis, C. C.; Elisaf, M. S.; Mikhailidis, D. P.; Tselepis, A. D.24-Nov-2015
Implication of lipoprotein associated phospholipase A(2) activity in oxLDL uptake by macrophagesMarkakis, K. P.; Koropouli, M. K.; Grammenou-Savvoglou, S.; van Winden, E. C.; Dimitriou, A. A.; Demopoulos, C. A.; Tselepis, A. D.; Kotsifaki, E. E.24-Nov-2015
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Tellis, C.; Goudevenos, I. A.24-Nov-2015
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Tellis, C. C.; Goudevenos, I. A.24-Nov-2015
Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60)Dimitriou, A. A.; Stathopoulos, P.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Goudevenos, J.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015
PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1 beta effectsVerouti, S. N.; Fragopoulou, E.; Karantonis, H. C.; Dimitriou, A. A.; Tselepis, A. D.; Antonopoulou, S.; Nomikos, T.; Demopoulos, C. A.24-Nov-2015
A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alpha IIb cytoplasmic domain inhibits platelet activationKoloka, V.; Christofidou, E. D.; Vaxevanelis, S.; Dimitriou, A. A.; Tsikaris, V.; Tselepis, A. D.; Panou-Pomonis, E.; Sakarellou-Daitsiotis, M.; Tsoukatos, D. C.24-Nov-2015
A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin IIb cytoplasmic domain, inhibits platelet activationKoloka, V.; Christofidou, E. D.; Vaxevanelis, S.; Dimitriou, A. A.; Tsikaris, V.; Tselepis, A. D.; Panou-Pomonis, E.; Sakarellos-Daitsiotis, M.; Tsoukatos, D. C.24-Nov-2015
The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatmentKalantzi, K. I.; Dimitriou, A. A.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015
Platelet-derived microparticles inhibit the oxidative modification of LDL possibly through their phosphatidylserine and plasmalogen contentMitsios, J. V.; Tsironis, L. D.; Dimitriou, A. A.; Tselepis, A. D.24-Nov-2015